🇺🇸 FDA
Pipeline program

CMV-TCR-T cells

HXYT-005

Phase 1 mab completed

Quick answer

CMV-TCR-T cells for CMV Infection or Reactivation After Allogenic HSCT is a Phase 1 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
CMV Infection or Reactivation After Allogenic HSCT
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials